You Don't "Own" Your Own Genes
Thursday, March 28, 2013
Researchers raise alarm about loss of individual "genomic liberty" due to gene patents that may impact the era of personalized medicine.
Genetic Mechanism could Trigger Long-term Memory
Tuesday, March 26, 2013
The researchers believe the discovery of this mechanism adds another piece to the puzzle in the ongoing effort to uncover the mysteries of memory.
Integromics Invests in the Optimization of Computing Performance for Bioinformatics Applications
Friday, March 22, 2013
Key collaboration with European experts of HPC to bring new big-data computing solutions into genomics.
Genetic Analysis of UK Biobank Participants
Friday, March 22, 2013
UK Biobank announces plans to undertake detailed DNA analysis of its 500,000 participants to better understand the complex interaction of lifestyle and genes in causing life-threatening and disabling disorders.
Researchers Pair Experiments with Computer Models to Peer into Cells
Wednesday, March 20, 2013
BBSRC-funded researchers have developed a new strategy that can give scientists a better insight into how complex molecular machineries function in living cells.
Ángel Carracedo: ''Only 50% of First-Line Drugs are Effective''
Wednesday, March 20, 2013
The Professor of Legal Medicine and director of the Genomic Medicine lab at the University of Santiago de Compostela, talked of the future challenges of the field of pharmacogenetics in the clinic.
National Study to Examine Risks, Benefits in Emergent Whole Genome Sequencing
Tuesday, March 19, 2013
UCSF School of Pharmacy faculty member to lead four-year, $2.4 million project.
Bio-Rad Receives Award for QX100 Droplet Digital PCR System
Thursday, March 14, 2013
Company receives Frost & Sullivan 2012 North American Laboratory Researchers’ Choice: Future market leader of digital PCR technology award.
Oncodesign and OSEO Announce Funding of EUR 13.4 Million
Tuesday, March 12, 2013
This private-public partnership project, which aims to put in place the first national subsidiary dedicated to personalized medicine in oncology, has a EUR 41 million overall investment budget.
|
|
|
|
|
|
